Fate Therapeutics reported a net margin of -1,420.70% for the quarter ended Jun 2026. These financial ratios cover 56 quarters of results from Sep 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2012 | Dec2012 | Mar2013 | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EBT Margin | -381.96% | -404.74% | -402.13% | -443.97% | -564.74% | -138.74% | -42.21% | -6,236.23% | -2,396.19% | -2,605.07% | -2,437.35% | -594.45% | -1,559.50% | -3,111.51% | -2,329.28% | -1,785.37% | -1,847.21% | -2,374.07% | -2,396.69% | -1,420.70% | ||||||||||||||||||||||||||||||||||||
| EBIT Margin | -383.99% | -406.48% | -404.40% | -448.05% | -576.67% | -145.23% | -48.48% | -6,705.79% | -2,637.81% | -2,868.44% | -2,652.88% | -665.73% | -1,703.87% | -3,319.78% | -2,534.07% | -1,938.54% | -1,995.12% | -2,536.23% | -2,540.42% | -1,495.39% | ||||||||||||||||||||||||||||||||||||
| EBITDA Margin | -383.99% | -406.48% | -404.40% | -448.05% | -576.67% | -145.23% | -48.48% | -6,705.79% | -2,637.81% | -2,868.44% | -2,652.88% | -665.73% | -1,703.87% | -3,319.78% | -2,534.07% | -1,938.54% | -1,995.12% | -2,536.23% | -2,540.42% | -1,495.39% | ||||||||||||||||||||||||||||||||||||
| Operating Margin | -383.99% | -406.48% | -404.40% | -448.05% | -576.67% | -145.23% | -48.48% | -6,705.79% | -2,637.81% | -2,868.44% | -2,652.88% | -665.73% | -1,703.87% | -3,319.78% | -2,534.07% | -1,938.54% | -1,995.12% | -2,536.23% | -2,540.42% | -1,495.39% | ||||||||||||||||||||||||||||||||||||
| Net Margin | -381.96% | -404.74% | -402.13% | -443.97% | -564.74% | -138.74% | -42.21% | -6,236.23% | -2,396.19% | -2,605.07% | -2,437.35% | -594.45% | -1,559.50% | -3,111.51% | -2,329.28% | -1,785.37% | -1,847.21% | -2,374.07% | -2,396.69% | -1,420.70% | ||||||||||||||||||||||||||||||||||||
| FCF Margin | -338.21% | -519.43% | -405.65% | -341.19% | -425.36% | -185.02% | -54.37% | -3,289.60% | -1,997.84% | -2,196.78% | -1,736.94% | -477.81% | -973.13% | -1,499.84% | -2,148.86% | -1,360.72% | -1,526.54% | -1,790.07% | -2,391.15% | -1,127.76% | ||||||||||||||||||||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 1,000.12M | 953.01M | 889.92M | 832.72M | 778.20M | 727.46M | 667.95M | 607.55M | 564.27M | 525.00M | 538.05M | 549.35M | 511.89M | 467.83M | 419.68M | 385.15M | 357.65M | 331.30M | 301.93M | 272.51M | ||||||||||||||||||||||||||||||||||||
| Invested CapitalInvested Cap. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.05 | 0.06 | 0.07 | 0.08 | 0.09 | 0.13 | 0.20 | 0.20 | 0.19 | 0.12 | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | ||||||||||||||||||||||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Times Interest Earned | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Valuation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -104.02 | -81.07 | -50.54 | -29.15 | -25.72 | -15.95 | -22.48 | -8.06 | -4.49 | -8.45 | -17.80 | -9.28 | -8.31 | -3.25 | -2.39 | -3.77 | -4.52 | -3.48 | -4.48 | -10.65 | ||||||||||||||||||||||||||||||||||||
| Price to SalesP/S | 397.33 | 328.14 | 203.26 | 129.40 | 145.27 | 22.13 | 9.49 | 502.65 | 107.51 | 220.09 | 433.91 | 55.14 | 129.67 | 101.07 | 55.58 | 67.34 | 83.47 | 82.58 | 107.41 | 151.33 | ||||||||||||||||||||||||||||||||||||
| Price to BookP/B | 7.74 | 8.25 | 5.91 | 4.13 | 4.20 | 2.03 | 1.17 | 1.07 | 0.52 | 1.00 | 1.96 | 0.94 | 1.10 | 0.59 | 0.31 | 0.49 | 0.62 | 0.55 | 0.78 | 2.05 | ||||||||||||||||||||||||||||||||||||
| Enterprise Value | 4,973.36M | 4,985.07M | 3,169.01M | 1,831.41M | 1,671.15M | 545.48M | 150.79M | 91.03M | -140.73M | 53.69M | 451.74M | 68.55M | 101.67M | -91.09M | -149.89M | -94.42M | -70.10M | -90.60M | -170.52M | 39.93M | ||||||||||||||||||||||||||||||||||||
| EV to EBIT | -91.05 | -71.85 | -42.56 | -22.04 | -19.34 | -8.47 | -5.27 | -1.46 | 2.74 | -1.12 | -8.85 | -1.52 | -1.94 | 1.48 | 3.63 | 2.55 | 2.02 | 2.61 | 5.17 | -1.28 | ||||||||||||||||||||||||||||||||||||
| EV to EBITDA | -91.05 | -71.85 | -42.56 | -22.04 | -19.34 | -8.47 | -5.27 | -1.46 | 2.74 | -1.12 | -8.85 | -1.52 | -1.94 | 1.48 | 3.63 | 2.55 | 2.02 | 2.61 | 5.17 | -1.28 | ||||||||||||||||||||||||||||||||||||
| Market Capitalization | 5,652.07M | 5,600.98M | 3,742.78M | 2,400.26M | 2,176.28M | 981.71M | 559.69M | 468.97M | 209.00M | 368.87M | 835.28M | 373.43M | 398.60M | 187.98M | 90.54M | 128.41M | 145.32M | 113.05M | 139.53M | 315.07M | ||||||||||||||||||||||||||||||||||||
| Price to FCFP/FCF | -117.48 | -63.17 | -50.11 | -37.93 | -34.15 | -11.96 | -17.45 | -15.28 | -5.38 | -10.02 | -24.98 | -11.54 | -13.32 | -6.74 | -2.59 | -4.95 | -5.47 | -4.61 | -4.49 | -13.42 | ||||||||||||||||||||||||||||||||||||
| EV to FCF | -103.37 | -56.23 | -42.42 | -28.94 | -26.23 | -6.65 | -4.70 | -2.97 | 3.62 | -1.46 | -13.51 | -2.12 | -3.40 | 3.27 | 4.28 | 3.64 | 2.64 | 3.70 | 5.49 | -1.70 | ||||||||||||||||||||||||||||||||||||
| EV to CFO | -149.01 | -70.92 | -49.05 | -34.45 | -30.36 | -7.24 | -5.22 | -3.19 | 3.68 | -1.47 | -13.55 | -2.12 | -3.46 | 3.28 | 4.43 | 3.84 | 2.88 | 3.89 | 5.53 | -1.71 | ||||||||||||||||||||||||||||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -383.99% | -406.48% | -404.40% | -448.05% | -576.67% | -145.23% | -48.48% | -6,705.79% | -2,637.81% | -2,868.44% | -2,652.88% | -665.73% | -1,703.87% | -3,319.78% | -2,534.07% | -1,938.54% | -1,995.12% | -2,536.23% | -2,540.42% | -1,495.39% | ||||||||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -19.93% | -24.89% | -30.20% | -37.99% | -46.47% | -50.27% | -42.39% | -42.99% | -39.56% | -39.21% | -43.23% | -37.99% | -41.44% | -48.98% | -51.21% | -53.96% | -53.02% | -50.03% | -51.40% | -55.68% | ||||||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -17.96% | -22.63% | -27.41% | -33.60% | -39.85% | -41.59% | -37.94% | -37.73% | -33.88% | -33.01% | -36.31% | -32.30% | -34.92% | -41.25% | -43.85% | -46.16% | -45.30% | -41.25% | -43.00% | -46.01% |